Paralon

Quick links to important sections

Paralon

Method of action: Miorelaxant

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Paralon

Property Description
Active ingredients Acetaminophen, Chlorzoxazone
Form Oral Tablet
Pharmacological class Analgesic-Muscle Relaxant Combination
Common use Acute musculoskeletal pain and spasm
Origin Synthetic compound

Paralon is a synthetic, fixed-dose combination medication classified as an Analgesic-Muscle Relaxant Combination. It is specifically designed to provide simultaneous relief from both the pain and the associated muscle spasm characteristic of acute musculoskeletal conditions. The drug's identity stems from its formulation, which integrates two distinct compounds, ensuring a comprehensive, dual approach to managing acute physical discomfort.

What Type of Medication is Paralon?

Paralon belongs to the Analgesic-Muscle Relaxant Combination pharmacological class, distinguishing it as a therapeutic agent that addresses two primary symptomatic aspects concurrently. This combined-action approach facilitates the management of muscle spasms and related pain. The combination is utilized for its utility in addressing the discomfort and restricted mobility linked to muscle injury. Unlike single-entity pain relievers or dedicated muscle relaxants, this fixed combination product is clinically recognized for offering an integrated functional benefit intended for acute, painful musculoskeletal conditions, such as those arising from sports injuries or acute muscle strain.

Composition and Physical Form of Paralon

The composition of Paralon is defined by its two key synthetic active ingredients: Acetaminophen and Chlorzoxazone. Acetaminophen (also known as Paracetamol) is the non-opioid analgesic component, while Chlorzoxazone is a benzoxazole derivative that functions as a centrally operating muscle relaxant. The combination is formulated to work synergistically to improve patient comfort beyond what either agent could achieve alone. The medication is presented as an oral tablet, representing a solid dosage form intended for the oral route of administration, distinguishing it from topical or injectable formulations.

Paralon’s General Purpose for Musculoskeletal Discomfort

The general purpose of Paralon is the symptomatic mitigation of acute pain and spasms often associated with muscle strains, sprains, or trauma. The combined action aims to lessen the discomfort caused by both the muscle's involuntary tightening and the subsequent pain sensation. By managing these dual symptoms, the medication assists in restoring functional comfort and reducing the overall rigidity felt during episodes of acute musculoskeletal tension, focusing strictly on relief from these immediate symptoms.

Regulatory References

  1. National Library of Medicine (NLM) - DailyMed
  2. MedlinePlus: Chlorzoxazone Drug Information

What side effects are possible with Paralon?

Possible Side Effects and Safety Information

The safety profile of Paralon (Acetaminophen and Chlorzoxazone) is derived from its two active components, with adverse reactions formally categorized by frequency and the body system affected (System-Organ Class or SOC) in regulatory documents. The most frequently documented effects, classified as Common, relate primarily to the Central Nervous System.

System Organ Class (SOC) Common Adverse Reactions (Official Terminology)
Nervous System Drowsiness, Dizziness, Lightheadedness, Malaise
Gastrointestinal Disorders Gastrointestinal upset, Nausea

Serious adverse reactions are explicitly detailed in official prescribing information, reflecting the most critical safety concerns. The potential for Serious Hepatotoxicity and Acute Liver Failure is a primary constraint, chiefly linked to the Acetaminophen component but also reported with Chlorzoxazone. This risk is a key factor in limiting the use of the medicine, and patients with Severe Hepatic Impairment are often subject to a safety restriction.

Other clinically significant, though Rare, safety events include Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Furthermore, Central Nervous System effects like drowsiness are noted to be more common at the initiation of therapy, a time-related safety pattern common to centrally acting muscle relaxants. The safety information requires caution when the drug is used in Older Adults due to their increased susceptibility to CNS effects.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents define the Paralon overdose profile based on the combined toxicological effects of its two active components. Suspected overdose can lead to acute outcomes related to Central Nervous System (CNS) and respiratory depression, or delayed, severe outcomes related to the hepatic system.

Documented Manifestations and Severe Outcomes

An overdose may initially present with signs such as nausea, vomiting, abdominal pain, and excessive sweating. More severe manifestations documented in regulatory labeling include severe drowsiness, muscle weakness, and signs of liver injury such as jaundice or dark urine. Life-threatening outcomes listed by authorities include Acute Liver Failure, coma, and respiratory depression. Furthermore, individuals with a history of chronic alcohol abuse or pre-existing liver disease are listed as having an increased risk of severe liver damage.

Mandatory Emergency Actions

Regulatory authorities mandate specific actions for any suspected overdose. It is required to get medical help or contact a Poison Control Center right away, even if the exposed individual does not exhibit immediate symptoms. Emergency services must be called immediately if the person has collapsed, is having a seizure, has trouble breathing, or cannot be awakened. Overdose management typically involves supportive care, and for the acetaminophen component, the use of the antidote N-acetylcysteine and serum level estimations are required regulatory procedures.

Therapeutic Uses of Paralon

What Paralon Treats: Main Uses and Benefits

Paralon is generally used for the symptomatic relief of discomfort associated with acute, painful musculoskeletal conditions, such as muscle strains, muscle sprains, and acute low back or neck pain. It is used for managing symptoms of pain and muscular tension that often occur together. This approach contributes to easing the overall symptom load during periods of heightened symptoms.

The medication is commonly used when symptoms of muscular stiffness and restricted motion are present, often following trauma or excessive exertion. When symptoms interfere with daily functioning, the medication can assist with easing the discomfort and stiffness. This assistance is relevant in contexts involving heightened systemic burden and may help patients cope more steadily with symptom fluctuations.

“The medication is used in situations involving certain distressing symptoms of acute pain and muscle tension.”

Quick Fact: Symptomatic Support in Acute Musculoskeletal Spasm

Regulatory References

  1. NIH DailyMed official drug label

Eligibility and Restrictions for Use

The official eligibility profile for Paralon (Acetaminophen/Chlorzoxazone) is determined by regulatory requirements for its two active components.

Populations for Whom Use is Contraindicated

Paralon must not be used by patients with severe hepatic impairment or severe active liver disease. Use is also strictly contraindicated if the patient has a known hypersensitivity to Acetaminophen, Chlorzoxazone, or any component of the formulation. Additionally, patients must not use Paralon concurrently with any other product containing Acetaminophen due to the risk of severe liver toxicity.

Age-Related and Conditional Eligibility

Use is generally established for adults and adolescents 12 years of age and older. Use is not established or not recommended for children younger than 12 years. Caution is required in patients with pre-existing hepatic disease (non-severe), severe renal impairment, or conditions such as alcoholism or chronic malnutrition. For older adults, caution is advised due to a higher likelihood of age-related hepatic concerns.

Pregnancy and Lactation Status

Use during pregnancy is restricted and should occur only when the potential benefits outweigh the possible risks. For lactating women, the status is considered not established due to insufficient regulatory data on the excretion of Chlorzoxazone into human milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation establishes specific interaction constraints for Paralon, focusing on hepatic risk modification and pharmacodynamic reinforcement. The use of the medication is formally contraindicated in individuals with severe hepatic impairment or severe active liver disease, a restriction driven by the Acetaminophen component.

Pharmacodynamic and Substance Interactions

The co-administration of the Chlorzoxazone component with other Central Nervous System (CNS) depressants, including sedatives, hypnotics, or opioid analgesics, results in an officially documented additive CNS depressant effect. This same pharmacodynamic effect is noted when Paralon is combined with alcohol.

Further restrictions are mandated for the Acetaminophen component: consumption of three or more alcoholic drinks daily is restricted due to a significantly increased risk of severe liver damage. Regulatory authorities also restrict co-administration with any other medicinal products containing Acetaminophen to prevent surpassing the maximum daily dose and risking hepatotoxicity.

Metabolic and Population Cautions

The official profile notes potential metabolic interactions with substances that affect hepatic enzymes, such as CYP2E1, which may modify the exposure to the toxic metabolite of Acetaminophen. Population-specific cautions are also documented, noting that patients with preexisting liver disease or certain conditions like chronic malnutrition have a documented increased susceptibility to these interaction-related risks.

Mechanism of Action

Paralon functions as a competitive antagonist at the postjunctional nicotinic acetylcholine (ACh) receptors located at the neuromuscular junction of skeletal muscle fibers

. Structurally, Paralon contains moieties that facilitate binding to the alpha subunits of the pentameric nicotinic receptor, which are the normal binding sites for the endogenous neurotransmitter, ACh. The binding of Paralon to the receptor prevents the association of ACh, thereby stabilizing the receptor in a non-activated, closed conformation. This blockade physically prevents the transient opening of the intrinsic ligand-gated ion channel and subsequent inward flux of sodium ions (Na^+). The resulting persistent absence of Na^+ influx prevents the requisite depolarization of the motor endplate membrane. This molecular inhibition of depolarization translates to an intracellular failure to initiate the action potential necessary for muscle fiber excitation. The system-level physiological consequence of this sustained inhibition is the cessation of voluntary skeletal muscle contraction.

Dosage and Administration Information

How to Use Paralon: Standard Administration Guidelines

The administration of Paralon, a fixed-dose combination of acetaminophen and chlorzoxazone, follows standardized clinical principles. This section describes the standard adult usage patterns, dose limits, and procedural requirements for its labeled indication, strictly focusing on administration details.


Administration Scope

Feature Guideline Overview
Route of administration The medication is formulated as an Oral Tablet and must be taken exclusively via the oral route.
Dosing schedule Individual doses are based on the range for the chlorzoxazone component, typically starting at 250 mg and extending up to 750 mg per single dose in adults.
Frequency and Timing Administration is typically required three to four times daily, which establishes a mandatory dosing interval of every six to eight hours between administrations.
Age-group administration rules Use is restricted to adult patients; the medication is not recommended for the pediatric population. Cautionary principles apply when considering administration in older adults.
Missed-dose rules If a dose is missed and it is nearly time for the subsequent dose, the missed dose should be skipped to prevent an overdose. Patients are instructed not to take a double dose.

Procedural Context and Duration

Paralon is intended for short-term symptomatic management only. The total duration of use is typically limited, often ranging from one to four weeks. It is used as an adjunct to other measures like physical therapy and rest. The administration protocol mandates that the dosage should be reduced to the lowest effective level once the desired therapeutic response is achieved, to prevent unnecessary extended use.

These instructions define the standardized pattern for using the medication, focusing solely on procedural and dose management.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Paralon


1. Evidence for Use in Acute Musculoskeletal Conditions

The research primarily consists of short-term randomized controlled trials (RCTs) that evaluated the use of the combination's components in patients experiencing conditions characterized by acute or disruptive episodes of pain and muscle tension. These trials were studied for their use in conditions marked by functional limitations, such as acute strains, sprains, or non-specific low back pain.

Researchers in these trials monitored patient-reported outcomes describing perceived discomfort and outcomes reflecting daily functioning or activity level. Meta-analyses describe patterns of measurement in patient-reported outcomes compared to an inactive substance (placebo) used in research exploring how symptoms change over time.


2. Trial Comparisons Against Placebo and Other Treatments

Clinical trials have explored how the combination or its muscle relaxant component performs when evaluated in comparison to an inactive placebo and against other active treatments, such as single-agent pain relievers or other muscle relaxants. This research examined different outcomes describing episodic or acute changes in patient condition.

Systematic reviews describe patterns of measurement in patient-reported outcomes compared to placebo in research exploring short-term symptom changes. Comparative evidence is lacking for the specific Paralon combination against all other individual muscle relaxant and analgesic fixed-dose products.


3. Summary of Evidence Limitations and Uncertainty

The available evidence for Paralon is primarily relevant in trials assessing short-term or episodic symptom patterns. Most clinical trials have focused on very brief periods of treatment, with limited follow-up durations, typically lasting less than two weeks. Long-term effects are not fully established, and there is limited information for long-term outcomes or how the combination may affect patients over a sustained period or in cases of chronic, continuous discomfort.

Evidence quality varies across studies, and findings were mixed across different meta-analyses, complicating definitive conclusions about its comparative performance. The lack of high-quality, direct head-to-head comparisons against all alternative treatments means that comparative evidence is lacking for its specific place among all available acute pain and muscle spasm therapies.

Frequently Asked Questions (FAQ)

Common questions about Paralon (FAQ)


Q: Is Paralon a type of painkiller or something else?

A: Paralon is officially classified as an Analgesic-Muscle Relaxant Combination. This means it contains two distinct active ingredients: one component acts as an analgesic, or pain reliever, and the other component functions as a muscle relaxant. This combination is intended to address both pain and the muscle spasms associated with acute musculoskeletal conditions.


Q: How quickly should I expect to feel the effects of Paralon?

A: According to the official product information, the muscle relaxant component of Paralon (Chlorzoxazone) is absorbed relatively quickly. Blood levels are usually detectable within 30 minutes, and the highest concentration in the blood is typically reached in approximately one to two hours after taking the tablet.


Q: What does Paralon actually do inside the body?

A: Paralon works by acting on the central nervous system, specifically targeting areas in the spinal cord and the lower regions of the brain. Its mechanism is to inhibit the nerve reflex pathways that are involved in causing muscle spasms. By doing this, it helps to reduce the muscle tension and provides relief from the associated discomfort.


Q: Is it normal to feel a bit dizzy when starting Paralon?

A: Yes, regulatory documents list dizziness, drowsiness, and lightheadedness as common side effects associated with this medication. Official safety information indicates that these types of central nervous system effects are often noted to be more apparent when treatment is first initiated.


Q: Can Paralon be taken with common over-the-counter medicines like ibuprofen?

A: The official label strongly warns against combining Paralon with any other products that contain Acetaminophen, which is one of its active ingredients. While non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen are not strictly contraindicated, combining medications may increase the risk of certain side effects. Information regarding combination use is best reviewed by a healthcare professional.


Q: Are there any specific foods or drinks you should avoid while on Paralon?

A: Official product information explicitly advises against the consumption of alcohol while taking Paralon due to additive depressant effects and an increased risk of liver damage. Additionally, excessive intake of caffeine, found in products like coffee, tea, or chocolate, should be avoided as it may increase the central nervous system side effects like drowsiness and dizziness.


Q: Is it safe to drink coffee while taking Paralon?

A: Because Paralon can cause drowsiness and dizziness, official safety documents recommend avoiding excessive intake of caffeine. The potential for increased central nervous system side effects suggests that the intake of highly caffeinated products should be managed carefully while taking this medication.


Q: Is Paralon considered safe for children?

A: According to regulatory information regarding its use in specific populations, the safety and efficacy of Paralon have generally not been established for children under 12 years of age. Therefore, the medication is typically not recommended for use in the pediatric population.


Q: How long can someone typically stay on Paralon?

A: Paralon is intended for short-term symptomatic management only. Official administration guidelines indicate that the total duration of use is typically limited. Treatment is generally used for a brief period, often ranging from one to four weeks, alongside rest and physical therapy.


Q: Can Paralon affect your blood pressure?

A: While changes in blood pressure are not listed among the common side effects, regulatory documents note that a fast heartbeat (tachycardia) has been reported as a rare side effect. Concerns about the medication affecting blood pressure should be reviewed with a healthcare provider.


Q: How long does Paralon stay in your system after stopping it?

A: Regulatory documents indicate that the muscle relaxant component of Paralon is quickly broken down by the body and is largely eliminated through the urine. Less than one percent of a dose is excreted unchanged within 24 hours of administration.


Q: Are there any long-term side effects associated with taking Paralon for years?

A: Clinical trials for Paralon have primarily focused on short-term use, typically lasting less than two weeks. Consequently, official research summaries explicitly state that long-term effects are not fully established, and there is limited regulatory information available regarding the effects of sustained use over many years.


Q: What is the scientific research saying about the effectiveness of Paralon?

A: The effectiveness of Paralon is supported by short-term randomized controlled trials (RCTs). Studies suggest the combination of its components shows effectiveness in reducing both discomfort and muscle tension associated with acute musculoskeletal conditions when compared to an inactive substance (placebo).


Q: Can Paralon affect your sleep patterns?

A: Yes, Paralon may affect your sleep patterns due to its action on the central nervous system. Official adverse reaction reports commonly list side effects such as drowsiness and malaise (a general feeling of discomfort) which may interfere with normal sleep.


Q: Does Paralon interact with alcohol, and if so, how?

A: Yes, Paralon interacts negatively with alcohol in two ways. First, alcohol consumption can cause an additive Central Nervous System (CNS) depressant effect, leading to increased dizziness and drowsiness. Second, chronic or excessive alcohol use significantly increases the risk of severe liver damage from the medication's Acetaminophen component.


Q: Why are there warnings about Paralon and liver function?

A: Warnings are issued because one of Paralon's active ingredients is Acetaminophen, which carries a known risk of severe hepatotoxicity (liver injury). Additionally, the other component, Chlorzoxazone, has been rarely linked to its own serious, idiosyncratic form of liver toxicity. This makes the potential for liver harm a primary safety constraint.


Q: What are the typical patient experiences when first starting Paralon?

A: Patients commonly report experiencing Central Nervous System (CNS) effects when first starting this medication. These typically include symptoms such as drowsiness, dizziness, lightheadedness, and a general feeling of malaise. Official safety information notes that these effects are often more noticeable during the initial days of therapy.


Q: Is Paralon safe for people with kidney problems (informational)?

A: Regulatory guidance advises caution when Paralon is used by patients with severe renal impairment (severe kidney problems). Due to the way one of the components is processed by the body, dose adjustments or longer intervals between doses may be necessary to mitigate risk in this population.


Q: Is it true that you can't drive while taking Paralon?

A: The official label issues a general warning that Paralon may cause drowsiness, dizziness, and impairment of thinking and judgment. Patients are cautioned to avoid operating a motor vehicle, driving, or engaging in other hazardous activities until they are fully aware of how the drug affects them individually.


Q: What happens if you miss a dose of Paralon?

A: If a dose is missed and it is almost time for your subsequent scheduled dose, official administration rules state that the missed dose should be skipped. Official rules indicate that a double dose should not be taken, as this action increases the risk of overdose.


Q: Does Paralon need to be taken with food?

A: The administration section generally indicates that Paralon can be taken with or without food. Taking the medication with food may be recommended for some individuals as it can help reduce the chances of experiencing gastrointestinal upset, which is a common side effect.


Q: What is the difference between the brand name and generic versions of Paralon?

A: Regulatory bodies require that generic versions of a medication, like Paralon, demonstrate bioequivalence to the brand name product. This means that the generic formulation must contain the exact same active ingredients in the same strength and is expected to have the same clinical effect.


Q: Can you take Paralon while pregnant (general curiosity, not advisory)?

A: The safety of the muscle relaxant component of Paralon for fetal development is not fully established in regulatory data. It is restricted for use during pregnancy and should only be administered if the potential benefits are deemed by a physician to outweigh the possible risks to the fetus.


Q: What should I do if a side effect seems a bit unusual?

A: Official warnings state that if a patient notices signs of a serious reaction, such as a rash, fever, dark urine, hives, or yellowing of the skin or eyes (jaundice), the individual should immediately seek medical attention. Regulatory documents indicate that patients who notice signs of a serious reaction should immediately seek medical attention.


Q: What are some of the less common but serious side effects of Paralon?

A: While rare, serious adverse events noted in regulatory documentation include signs of Severe Cutaneous Adverse Reactions (SCARs), which are severe skin reactions like rash or blistering. Additionally, any sign of liver injury (hepatotoxicity) is considered a serious event requiring immediate attention.


Q: How should Paralon be stored (e.g., room temperature, fridge)?

A: Paralon tablets should be stored at Controlled Room Temperature, which typically ranges between 20 C and 25 C (68 F and 77 F). The medication must be kept in a cool, dry place and protected from excessive heat, moisture, and direct light to maintain its strength and quality.


Q: Can I crush or split a Paralon tablet if I have trouble swallowing?

A: The ability to crush or split any tablet depends on its physical design (whether it is scored) and if it is formulated as an extended-release product. Reviewing the official product information or consulting a pharmacist is necessary to confirm if a specific tablet strength is designed to be split or crushed safely.

How should Paralon be stored and disposed of?

Storage & Disposal

Storage: Keep Paralon securely out of the reach and sight of children and pets. If specific instructions are not on the label, store the medicine at controlled room temperature (typically 59 F to 86 F or 15 C to 30 C) in a cool, dry place. Protect the drug from excessive heat, moisture, and direct light to maintain its strength and quality throughout its shelf-life.


Disposal: The preferred method for discarding unused or expired medicine is through a community drug take-back program or an authorized mail-back service. Do not flush Paralon down the toilet or pour it down a sink unless the packaging or FDA guidance explicitly instructs you to do so. If take-back options are unavailable, mix the medicine with an undesirable substance, such as used coffee grounds or cat litter, place the mixture in a sealed bag or container, and discard it in your household trash. Scratch out all personal information on the prescription label before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Paralon found in:

A-Z Index: